Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes-Reference-Cited by-同舟云学术

Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes

Published:2020-04-23 Issue:5 Volume:27 Page:989-998
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Alkaraki Arwa,Alshaer Walhan,Wehaibi Suha,Gharaibeh Lobna,Abuarqoub Duaa,Alqudah Dana A.,Al-Azzawi Hafsa,Zureigat Hadil,Souleiman Mamoun,Awidi Abdalla

Funder

Deanship of Academic Research, University of Jordan

King Abdullah II Fund for Development

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12282-020-01098-9.pdf

Reference38 articles.

1. Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer. 2012;118:5463–72.

2. Irvin WJ Jr, Carey LA. What is triple-negative breast cancer? Eur J Cancer. 2008;44:2799–805.